Clinical Trials Browser

Active not recruiting × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Artesunate × Clear all

NCT07022743 2025-09-05

Improving Treatment Outcomes in Chronic Myeloid Leukaemia Patients Using Imatinib and Artesunate Combination Therapy

Phase 2 Active not recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive